NCT05068752 2026-03-30Phase II Trial of Vemurafenib and Sorafenib in Pancreatic CancerHonorHealth Research InstitutePhase 2 Completed10 enrolled 15 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn